Sort
35,931 grants matching “parkinsons”
Grp94-selective inhibitors to treat heredity glaucoma
$416,063Robert J Deschenes · University Of South Florida · R01 · FY2017 · EY
Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's Diseas
$416,027M. Maral Mouradian · Rbhs-Robert Wood Johnson Medical School · R01 · FY2015 · AT
Mechanisms and Treatment of Cardiac and Skeletal Muscular Dysfunction in Barth Syndrome
$416,007Christina A. Pacak · University Of Minnesota · R01 · FY2022 · HL
Protection from Mucosal Pathology by Gut Microbiota during Experimental Colitis
$415,984Sarkis K Mazmanian · California Institute Of Technology · R01 · FY2020 · DK
Human mitochondrial fatty acid synthase
$415,983Stuart Smith · Children'S Hospital & Res Ctr At Oakland · R01 · FY2006 · GM
Human mitochondrial fatty acid synthase
$415,946Stuart Smith · Children'S Hospital & Res Ctr At Oakland · R01 · FY2007 · GM
Restoring functional connectivity following TBI
$415,901Gene Gabriel Gurkoff · University Of California At Davis · R01 · FY2017 · NS
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies
$415,807M. Maral Mouradian · Rbhs-Robert Wood Johnson Medical School · R01 · FY2019 · NS
DOSE RANGE STUDY OF REMACEMIDE AS ADJUNCT TO LEVODOPA IN PARKINSON'S DISEASE
$415,629Massachusetts General Hospital · M01 · FY2000 · RR
Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2020 · NS
Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2021 · NS
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2016 · NS
Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2018 · NS
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2015 · NS
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2018 · NS
Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2017 · NS
Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2019 · NS
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2017 · NS
Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinson's Disease
$415,625Darren John Moore · Van Andel Research Institute · R01 · FY2019 · NS
Neuropathology, Biomarker & Genetics Core C
$415,614John Q. Trojanowski · University Of Pennsylvania · U19 · FY2020 · AG
Neuropathology, Biomarker & Genetics Core C
$415,614John Q. Trojanowski · University Of Pennsylvania · U19 · FY2019 · AG
Hsp90 Dependent Rab Tethering
$415,591William Edward Balch · Scripps Research Institute, The · R01 · FY2010 · GM
Methamphetamine Research Program at Meharry Medical College
$415,505Hubert K. Rucker · Meharry Medical College · R24 · FY2009 · DA
Alpha-synuclein driven cellular changes and vocal dysfunction in Parkinson's Disease
$415,482Julie Elizabeth Miller · University Of Arizona · R21 · FY2021 · NS
Regulation of intracellular calcium signaling and phosphoinositide metabolism by IRBIT
$415,443Martin Kruse · Bates College · R15 · FY2023 · GM